{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:54:30Z","timestamp":1761630870184},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Vaccine-preventable viral infections are associated with increased risk of morbidity and mortality in immunocompromised patients. Current guidelines recommend routine screening and vaccination of all patients before solid organ transplantation. We studied rates of immunity against vaccine-preventable viruses in liver transplantation (LT) recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We retrospectively studied consecutive adult patients who underwent first deceased donor LT at a single center between August 2008 and October 2017. Viruses studied were hepatitis A (HAV), hepatitis B (HBV), varicella zoster virus (VZV), measles, and mumps. Hepatitis B surface antibody (anti-HBs) &lt;10 IU\/mL in HBV surface antigen-negative patients and negative IgG to other viruses was regarded as absent immunity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Five hundred and fifty-five patients underwent LT (72.4% male; median age, 55.0 y). Percentages of patients who lacked immunity to vaccine-preventable infections were HAV (31.8%), HBV (63.8%), measles (1.4%), mumps (6.6%), and VZV (3.8%). Age was positively associated with immunity (from either past exposure or vaccination) against most viruses, including HAV, measles, mumps, and VZV (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 for all). In contrast, older age was marginally associated with anti-HBs &lt;10 IU\/mL (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.046). No significant changes in immunity rates were observed during the study period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>A substantial number of patients undergoing LT are not immune to vaccine-preventable viruses at the time of assessment. This presents an opportunity for pre-LT vaccination and in particular younger patients may need to be targeted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002722","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T16:05:43Z","timestamp":1562601943000},"page":"2318-2322","source":"Crossref","is-referenced-by-count":11,"title":["Immunity to Vaccine-preventable Viral Infections in Australians Being Evaluated for Liver Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"Astrid","family":"Gardiner","sequence":"first","affiliation":[{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Liu","sequence":"additional","affiliation":[{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia."},{"name":"Sydney Medical School, University of Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bonnichsen","sequence":"additional","affiliation":[{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Joshi","sequence":"additional","affiliation":[{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Davis","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, Australia."},{"name":"Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone I.","family":"Strasser","sequence":"additional","affiliation":[{"name":"AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia."},{"name":"Sydney Medical School, University of Sydney, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation.","volume":"13 (Suppl 4)","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"R4-20231002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/ajt.15097","article-title":"Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates.","volume":"19","author":"Blanchard-Rohner","year":"2019","journal-title":"Am J Transplant"},{"issue":"25","key":"R5-20231002","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients.","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"R6-20231002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2016.01.008","article-title":"Infectious complications and vaccinations in the posttransplant population.","volume":"100","author":"Greendyke","year":"2016","journal-title":"Med Clin North Am"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/ajt.12125","article-title":"Travel medicine and transplant tourism in solid organ transplantation.","volume":"13 (Suppl 4)","author":"Kotton","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/TP.0000000000002173","article-title":"Presence of hepatitis B surface antibody in addition to hepatitis B core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen-negative patients undergoing kidney transplantation.","volume":"102","author":"Jeon","year":"2018","journal-title":"Transplantation"},{"issue":"10","key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1086\/644734","article-title":"Vaccination of solid-organ transplantation candidates.","volume":"49","author":"Chow","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"R10-20231002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.trre.2008.07.001","article-title":"Vaccination of the solid organ transplant recipient.","volume":"22","author":"Sester","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"issue":"6","key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.transproceed.2012.05.071","article-title":"Response to vaccination against hepatitis B virus with a schedule of four 40-\u03bcg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.","volume":"44","author":"Gutierrez Domingo","year":"2012","journal-title":"Transplant Proc"},{"issue":"3","key":"R12-20231002","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.transproceed.2012.10.012","article-title":"Are liver transplant recipients protected against hepatitis A and B?","volume":"45","author":"Andersson","year":"2013","journal-title":"Transplant Proc"},{"issue":"6","key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.transproceed.2012.05.020","article-title":"Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in spain.","volume":"44","author":"Guti\u00e9rrez Domingo","year":"2012","journal-title":"Transplant Proc"},{"key":"R14-20231002","first-page":"766A","article-title":"Varicella and measles immunity following pediatric liver transplant: a single-center\u2019s experience.","volume":"68","author":"Yoeli","year":"2018","journal-title":"Hepatology"},{"key":"R15-20231002","first-page":"278A","article-title":"The utility of the electronic medical records system (EMR) in improving the quality of care provided to patients with cirrhosis seen in the outpatient setting.","volume":"68","author":"Talaat","year":"2018","journal-title":"Hepatology"},{"issue":"11","key":"R16-20231002","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"R17-20231002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-3046.2005.00403.x","article-title":"Live virus immunization after orthotopic liver transplantation.","volume":"10","author":"Khan","year":"2006","journal-title":"Pediatr Transplant"},{"issue":"2","key":"R18-20231002","first-page":"201","article-title":"Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?","volume":"90","author":"Keeffe","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"R19-20231002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199801293380503","article-title":"Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.","volume":"338","author":"Vento","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"R20-20231002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/lt.500050301","article-title":"Severe clinical course of de novo hepatitis B infection after liver transplantation.","volume":"5","author":"Crespo","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"Supp","key":"R21-20231002","first-page":"S1","article-title":"Vaccine preventable diseases in australia, 2005 to 2007.","volume":"34","author":"Chiu","year":"2010","journal-title":"Commun Dis Intell Q Rep"},{"issue":"1","key":"R22-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose.","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R24-20231002","first-page":"305A","article-title":"Vaccine-preventable illness in alcoholic and non-alcoholic chronic liver disease: a nationwide cohort analysis.","volume":"68","author":"Vinsard","year":"2018","journal-title":"Hepatology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:30:11Z","timestamp":1696224611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002722","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}